Audrey Rodallec
Nantes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approval.
Journal: Antimicrobial agents and chemotherapy
Published: June 10, 2026
A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab.
Journal: Open forum infectious diseases
Published: March 27, 2026
Kinetics of Non-nucleoside Reverse Transcriptase Inhibitor Resistance-associated Mutations in HIV-1 Proviral Cellular Reservoirs in Non-nucleoside Reverse Transcriptase Inhibitor-experienced Persons.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 10, 2025
Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
Journal: Clinical and experimental immunology
Published: August 05, 2020
Previously unreported emergence of A265V substitution in the integrase gene in association with bictegravir virological failure.
Journal: International journal of antimicrobial agents
Published: February 10, 2020
Prototyping Trastuzumab Docetaxel Immunoliposomes with a New FCM-Based Method to Quantify Optimal Antibody Density on Nanoparticles.
Journal: Scientific reports
Published: September 30, 2019
Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study).
Journal: The Journal of antimicrobial chemotherapy
Published: December 18, 2017
HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
Journal: PLoS pathogens
Published: December 06, 2017
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen.
Journal: The Journal of antimicrobial chemotherapy
Published: October 16, 2017
Switching from abacavir/lamivudine plus nevirapine to abacavir/lamivudine/dolutegravir in virologically controlled HIV-infected adults (SWAD study).
Journal: Medecine et maladies infectieuses
Published: September 11, 2017
Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 04, 2017
Last Updated: 09/26/2026